|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.6500 GBX | 0.00% |
|
0.00% | +23.81% |
| Market Cap | 4.37M 5.8M 5.09M 4.69M 8.24M 552M 8.41M 56.4M 21.85M 271M 21.79M 21.31M 942M | P/E 2023 |
-1.63x | P/E 2024 | -1.69x |
|---|---|---|---|---|---|
| Enterprise Value | 3.74M 4.97M 4.36M 4.02M 7.06M 473M 7.2M 48.32M 18.72M 232M 18.66M 18.26M 807M | EV / Sales 2023 |
643,891,449x | EV / Sales 2024 | 198,657,512x |
| Free-Float |
42.82% | Yield 2023 * |
-
| Yield 2024 | - |
Last Transcript: Thalia Therapeutics Plc
| 3 months | +44.44% | ||
| 6 months | +23.81% | ||
| Current year | +23.81% |
| 1 week | 0.6 |  | 0.7 |
| 1 month | 0.55 | | 0.7 |
| Current year | 0.4 | | 0.95 |
| 1 year | 0.35 | | 1 |
| 3 years | 0.35 | | 2.1 |
| 5 years | 0.35 | | 10.43 |
| 10 years | 0.35 | | 35.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Solomon
CEO | Chief Executive Officer | 66 | 23/02/2026 |
Rachel Schiller
COO | Chief Operating Officer | - | - |
Fiona McLaughlin
CTO | Chief Tech/Sci/R&D Officer | 56 | 26/05/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Luke Cairns
BRD | Director/Board Member | 48 | 13/07/2020 |
| Chairman | 59 | 31/07/2023 | |
| Director/Board Member | 81 | 08/09/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 27/11/24 | Free | Founder | 6,000,000 | 1.5198% | ||
| 27/11/24 | Free | Director | 3,000,000 | 0.7599% | ||
| 27/11/24 | Free | Chairman | 3,000,000 | 0.7599% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | +73.33% | -59.38% | 7.18M | |
| +1.76% | +3.27% | +72.60% | +131.08% | 56.21B | |
| +0.55% | +8.49% | +77.09% | +100.93% | 55.38B | |
| +0.93% | +4.11% | -12.64% | -12.98% | 23.75B | |
| +0.36% | +3.42% | +9.61% | +407.11% | 23.19B | |
| +3.64% | +8.34% | +39.81% | -5.88% | 18.14B | |
| +1.47% | +6.16% | +40.97% | -29.54% | 16.84B | |
| +1.49% | +17.24% | +174.91% | +344.55% | 15.86B | |
| -0.83% | +2.06% | +23.70% | +182.37% | 13.56B | |
| +7.20% | +13.33% | +42.13% | - | 12.97B | |
| Average | +1.65% | +5.87% | +54.15% | +117.58% | 23.59B | |
| Weighted average by Cap. | +1.51% | +6.60% | +56.49% | +131.98% |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 0 0 0 0 0 0.25 0 0.03 0.01 0.12 0.01 0.01 0.42 | 0.01 0.01 0.01 0.01 0.01 0.92 0.01 0.09 0.04 0.45 0.04 0.04 1.57 |
| Net income | -1.27M -1.69M -1.48M -1.36M -2.39M -160M -2.44M -16.38M -6.35M -78.66M -6.33M -6.19M -274M | -1.06M -1.41M -1.23M -1.14M -2M -134M -2.04M -13.66M -5.29M -65.6M -5.28M -5.16M -228M |
| Net Debt | -1.03M -1.36M -1.2M -1.1M -1.94M -130M -1.98M -13.26M -5.14M -63.65M -5.12M -5.01M -222M | -626K -831K -730K -672K -1.18M -79.03M -1.2M -8.08M -3.13M -38.79M -3.12M -3.05M -135M |
Employees
3
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/07/26 | GBX 0.6500 | 0.00% | 0 |
| 01/07/26 | GBX 0.6500 | 0.00% | 9,735,131 |
| 30/06/26 | GBX 0.6500 | 0.00% | 215,510 |
| 29/06/26 | GBX 0.6500 | 0.00% | 40,854 |
| 26/06/26 | GBX 0.6500 | 0.00% | 3,354,651 |
- Stock Market
- Stocks
- THAT Stock
Select your edition
All financial news and data tailored to specific country editions
